4.6 Article

Co-Occurrence of Germline Genomic Variants and Copy Number Variations in Hereditary Breast and Colorectal Cancer Patients

Journal

GENES
Volume 14, Issue 8, Pages -

Publisher

MDPI
DOI: 10.3390/genes14081580

Keywords

hereditary breast and ovarian cancer syndrome; colorectal cancer; whole exome sequencing; PMS2; copy number alteration

Ask authors/readers for more resources

This study used whole exome sequencing to test three unrelated patients with breast and colorectal cancer who met the clinical criteria for HBOC. Several variants and copy number variations were identified that potentially contribute to cancer risk and prognosis. Copy number imbalances encompassing PMS2, a gene involved in the DNA mismatch repair pathway, were observed in all patients, along with gains in the POLE2 gene associated with DNA replication and other potentially damaging germline variants. Overall, concurrent genomic alterations were described that may increase the risk of breast and colorectal cancers in HBOC patients.
Hereditary Breast and Ovarian Cancer (HBOC) syndrome is an autosomal dominant disease associated with a high risk of developing breast, ovarian, and other malignancies. Lynch syndrome is caused by mutations in mismatch repair genes predisposing to colorectal and endometrial cancers, among others. A rare phenotype overlapping hereditary colorectal and breast cancer syndromes is poorly characterized. Three breast and colorectal cancer unrelated patients fulfilling clinical criteria for HBOC were tested by whole exome sequencing. A family history of colorectal cancer was reported in two patients (cases 2 and 3). Several variants and copy number variations were identified, which potentially contribute to the cancer risk or prognosis. All patients presented copy number imbalances encompassing PMS2 (two deletions and one duplication), a known gene involved in the DNA mismatch repair pathway. Two patients showed gains covering the POLE2 (cases 1 and 3), which is associated with DNA replication. Germline potentially damaging variants were found in PTCH1 (patient 3), MAT1A, and WRN (patient 2). Overall, concurrent genomic alterations were described that may increase the risk of cancer appearance in HBOC patients with breast and colorectal cancers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available